Past Event
In-Person
Kigali
HIV
Symposium at IAS 2025: How Long-acting Drugs Can Help End the HIV Pandemic in Africa
15 July 2025
LB
Linda-Gail Bekker
MBChB, DTMH, DCH, FCP(SA), PhD
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
Biography
Prof Linda-Gail Bekker (MBChB, DTMH, DCH, FCP (SA), PhD) is the Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, UCT and Chief Executive Officer of the Desmond Tutu Health Foundation. Prof Bekker is a physician, scientist and infectious disease specialist. Her research interests include programmatic and action research around antiretroviral roll out and TB integration, prevention of HIV in women, youth and MSM. She is PI of the NIH (USA) funded UCTCTU and remains actively involved in the work of the four associated clinical research sites and four DAIDS networks. She has led numerous investigator driven studies in HIV treatment, prevention and tuberculosis. Bekker serves on numerous international scientific and advisory committees and served as President-Elect (2014- 2016) and then President (2016-2018) of the International AIDS Society. She is a A+ rated scientist, has published >600 peer-reviewed papers.
RELATED PROGRAMS
LATEST RELATED MATERIALS
RELATED COURSES
HIV
70 min
Sarah Masyuko, Linda-Gail Bekker, Claudia Cortes
CME Series | Advancing HIV Prevention and Care in Women
This module offers practical insights into the unique needs of women in HIV care. Learn about the impact of menopause on women living with HIV, explore new prevention options tailored for women at risk, and review clinical data on long-acting HIV treatments. Designed for clinicians and public health professionals, this module supports gender-responsive, evidence-based care.
What Will Set You Apart?
After following this educational module, participants will:
- Understand the interplay between HIV and menopause in aging women living with HIV
- Learn about new prevention modalities for women at risk of HIV acquisition, and differentiate tailored approaches to prevention upscaling
- Be able to discuss clinical data supporting the use of novel long-acting treatment options for women
Is This Program for You?
The program is aimed at clinicians from various specialties who occasionally treat women affected by HIV, such as primary care physicians, family doctors, OBGYN, HIV care nurses, transgender healthcare clinicians, adolescent medicine professionals, and preventive medicine professionals, as well as public health workers and researchers engaged in HIV-related disciplines at varying degrees.
What Will You Cover in This Module?
- Understanding Menopause and HIV
- HIV Prevention for Women
- Long-Acting HIV Treatment Options